Health Sciences

Dyskeratosis congenita, or DC, is a rare, inherited disease for which there are limited treatment options and no cure. Typically diagnosed in childhood, the disorder causes stem cells to fail, leading to significant problems including bone marrow failure, lung fibrosis, dyskeratosis of the skin and intestinal atrophy and inflammation.

On Bonnie’s Bus, parked in a lot at Camp Caesar in Webster Springs, W. Va., Chana Schaffer is in a bit of a bind.

Public libraries serve communities in myriad ways, providing places where people gather to read, learn a new language, access the internet, pick up tax forms, or apply for jobs.

PHILADELPHIA - Mayor Jim Kenney has appointed Farzana Rashid Hossain, MD, an assistant professor of clinical medicine and a gastroenterologist at the Perelman School of Medicine at the Un

Try this thought experiment from the world of philosophy. Imagine a train moving quickly down a track. On its current route, call it Path A, five people stand fixed in place; in another direction, Path B, one immoveable individual waits. A single flip of a switch, at which you happen to be standing, shifts the train’s direction from Path A to B, saving five people but dooming one.

Two faculty members from the University of Pennsylvania have been selected for membership in the American Philosophical Society. They are Ronald Fairman and Rogers Smith.

A team of University of Pennsylvania researchers has developed a computer model that will aid in the design of nanocarriers, microscopic structures used to guide drugs to their targets in the body.

A new appreciation for the interplay between two cell nucleus proteins that lead both intertwined and separate lives is helping researchers better understand fatty liver disease, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania.

The bacteria that live in dental plaque and contribute to tooth decay often resist traditional antimicrobial treatment, as they can “hide” within a sticky biofilm matrix, a glue-like polymer scaffold.

In the era of precision medicine, targeting the mutations driving cancer growth, rather than the tumor site itself, continues to be a successful approach for some patients.